Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.cd004386.pub2PMID 16235360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

  2020cited by this paper
• Antimicrobial Prophylaxis in Immunocompromised Patients

  2012cited by this paper
• Urinary tract infection caused by Kluyvera ascorbata in an immunocompromised patient: Case report and review

  2005cited by this paper
• An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

  2005cited by this paper
• Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials.

  2005cited by this paper
• Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.

  2005cited by this paper
• Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients

  2005cited by this paper
• Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

  2005cited by this paper
• A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

  2004cited by this paper
• The antiviral prophylaxis of post-transplant lymphoproliferative disorder

  2004cited by this paper
• A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer

  2003cited by this paper
• Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.

  2003cited by this paper
• Infections in neutropenic cancer patients.

  2002cited by this paper
• Selective Bowel Decontamination for the Prevention of Infection in Acute Myelogenous Leukemia: A Prospective Randomized Trial

  2002cited by this paper
• Analysis of antimicrobial resistance among gram-negative bacilli and antimicrobial use in intensive care unit patients for 5 years in a Veterans Affairs medical center.

  2002cited by this paper
• Infections caused by viridans streptococci in patients with neutropenia.

  2002cited by this paper
• Treatment of febrile neutropenia: what is new?

  2002cited by this paper
• Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

  2001cited by this paper
• Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'.

  2001cited by this paper
• Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.

  2001cited by this paper
• Fluoroquinolone prophylaxis for bacterial infections in neutropenic patients with hematologic malignancies.

  2001cited by this paper
• Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.

  2001cited by this paper
• Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.

  2000cited by this paper
• Monotherapy with Intravenous Followed by Oral High-Dose Ciprofloxacin versus Combination Therapy with Ceftazidime plus Amikacin as Initial Empiric Therapy for Granulocytopenic Patients with Fever

  2000cited by this paper
• [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].

  2000cited by this paper
• Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.

  2000cited by this paper
• Antibacterial prophylaxis.

  2000cited by this paper
• Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.

  1999cited by this paper
• The prophylaxis of bacterial infections in neutropenic patients.

  1999cited by this paper
• Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes

  1998cited by this paper
• Oral Antimicrobial Prophylaxis in Bone Marrow Transplant Recipients: Randomized Trial of Ciprofloxacin versus Ciprofloxacin-Vancomycin

  1998cited by this paper
• Effect of Discontinuing Prophylaxis with Norfloxacin in Patients with Hematologic Malignancies and Severe Neutropenia

  1998cited by this paper
• Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.

  1998cited by this paper
• Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.

  1998cited by this paper
• Prevention of infection in the immunocompromised host.

  1998cited by this paper
• Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia.

  1998cited by this paper
• Planned progressive antimicrobial therapy in neutropenic patients

  1998cited by this paper
• [Infection prophylaxis in neutropenic patients].

  1997cited by this paper
• Use of fluoroquinolones as prophylactic agents in patients with neutropenia.

  1997cited by this paper
• Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants

  1997cited by this paper
• Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study

  1997cited by this paper
• The influence of antimicrobial prophylaxis on the microbial and clinical findings in patients after autologous bone marrow transplantation.

  1997cited by this paper
• Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial.

  1997cited by this paper
• Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.

  1996cited by this paper
• Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity

  1996cited by this paper
• Prevention of infection in neutropenic cancer patients.

  1996cited by this paper
• Infections in neutropenic patients II: Management

  1996cited by this paper
• Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin.

  1995cited by this paper
• Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.

  1995cited by this paper
• Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients

  1995cited by this paper
• Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole.

  1995cited by this paper
• [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin].

  1995cited by this paper
• Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

  1994cited by this paper
• Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.

  1994cited by this paper
• Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.

  1994cited by this paper
• A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

  1994cited by this paper
• Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

  1994cited by this paper
• Ceftazidime Compared with Piperacillin and Tobramycin for the Empiric Treatment of Fever in Neutropenic Patients with Cancer: A Multicenter Randomized Trial

  1994cited by this paper
• Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation

  1994cited by this paper
• Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.

  1994cited by this paper
• Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.

  1993cited by this paper
• Prevention of infections in the neutropenic patient.

  1993cited by this paper
• Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.

  1993cited by this paper
• Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group

  1993cited by this paper
• Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study.

  1993cited by this paper
• [Prophylaxis with fluoroquinolones in patients with neutropenia].

  1993cited by this paper
• Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.

  1993cited by this paper
• Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients.

  1993cited by this paper
• The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.

  1993cited by this paper
• Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

  1993cited by this paper
• Prophylactic use of ofloxacin in granulocytopenic patients with hematological malignancies during post-remission chemotherapy.

  1992cited by this paper
• [Comparison of Tarivid and Biseptol in the prevention of bacterial infections in patients with acute leukemia].

  1992cited by this paper
• Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.

  1992cited by this paper
• [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].

  1992cited by this paper
• Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.

  1992cited by this paper
• Prevention of viridans-group streptococcal septicemia in oncohematologic patients: A controlled comparative study on the effect of penicillin G and cotrimoxazole

  1992cited by this paper
• Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis

  1992cited by this paper
• Prophylaxis of bacterial infections after bone marrow transplantation. A randomized prospective study comparing oral broad-spectrum nonabsorbable antibiotics (vancomycin-tobramycin-colistin) to absorbable antibiotics (ofloxacin-amoxicillin).

  1991cited by this paper
• Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

  1991cited by this paper
• Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.

  1991cited by this paper
• Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.

  1991cited by this paper
• Prophylaxis, cost and effectiveness of therapy of infections caused by gram-positive organisms in neutropenic children.

  1991cited by this paper
• Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

  1991cited by this paper
• Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients.

  1990cited by this paper
• Gram-positive bacteraemia in granulocytopenic cancer patients.

  1990cited by this paper
• Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy

  1990cited by this paper
• Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.

  1990cited by this paper
• Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.

  1990cited by this paper
• Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.

  1990cited by this paper
• From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.

  1990cited by this paper
• [Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].

  1989cited by this paper
• Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.

  1989cited by this paper
• The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects.

  1989cited by this paper
• Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.

  1989cited by this paper
• Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.

  1989cited by this paper
• Prevention of infection in the neutropenic patient.

  1989cited by this paper
• Prophylactic co-trimoxazole versus norfloxacin in neutropenic children — perspective randomized study

  1989cited by this paper
• Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia

  1988cited by this paper
• The tolerability profile of prophylactic norfloxacin in neutropenic patients.

  1988cited by this paper
• [Prevention of bacterial infections after bone marrow graft by broad-spectrum oral antibiotics, absorbable (pefloxacin, penicillin) and non absorbable (cephalosporin, gentamycin, bacitracin)].

  1988cited by this paper

• Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practice.

  2026cites this paper
• Antibiotic susceptibility profile of bacterial isolates in paediatric cancer patients: a prospective cross-sectional study

  2026cites this paper
• Safety, recovery, and pharmacodynamics of CRISPR-Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study.

  2026cites this paper
• Beyond the Bundle: Reducing Central Line–Associated Bloodstream Infections on a Pediatric Hematology, Oncology, and Bone Marrow Transplant Unit

  2025cites this paper
• Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

  2025cites this paper
• Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland

  2025cites this paper
• Recommendations for antibacterial prophylaxis in children receiving chemotherapy: a joint initiative of SITIP and infectious disease group of AIEOP

  2025cites this paper
• Research priorities to address supportive care needs in acute myeloid leukaemia (AML)—results from a Delphi survey

  2025cites this paper
• The role of antibacterial prophylaxis in high-risk neutropenia: benefits, risks, and current perspectives.

  2025cites this paper
• Consensus guidelines for antibacterial prophylaxis in patients with neutropenia

  2025cites this paper
• Engineered neutrophil, an emerging immune therapeutic strategy

  2025cites this paper
• Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5‐Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study

  2025cites this paper
• Investigating the effect of sub MIC concentrations of ciprofloxacin, ceftriaxone and imipenem on the expression of virulence and toxin-antitoxin genes of Escherichia coli strains isolated from blood infections in leukemia patients.

  2025cites this paper
• Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin

  2025cites this paper
• Epidemiology of resistant bacterial infections in patients with hematological malignances or undergoing hematopoietic cell transplantation in Europe: a systematic review by the European Conference on Infections in Leukemia (ECIL).

  2025cites this paper
• Levofloxacin to Prevent Bacterial Infection in Patients With Acute Myeloid Leukemia Treated by Venetoclax and Azacitidine: A Toulouse-Bordeaux DATAML Registry Study

  2025cites this paper
• Impact of an antimicrobial stewardship bundle on the outcome of high-risk neutropenic patients with fever: a pre-post study

  2025cites this paper
• A Systematic Review Evaluating the Impact of Fibre Supplementation on Gut Health and Other Clinical Outcomes in Adults with Haematological Malignancies During Haematopoietic Stem Cell Transplantation

  2025cites this paper
• The Impact of Antibiotic Prophylaxis on Antibiotic Resistance, Clinical Outcomes, and Costs in Adult Hemato-Oncological and Surgical Patients: A Systematic Review and Meta-Analysis

  2025influential citation
• Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged ‘early’ after intensive induction

  2025influential citation
• Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation

  2025influential citation
• Alternative tests and measures for between-study inconsistency in meta-analysis

  2025cites this paper
• Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity

  2024cites this paper
• WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.

  2024cites this paper
• Pneumocystis jirovecii Pneumonia Infection in Breast Cancer Receiving Dose-dense Chemotherapy: A Case Report and Literature Review

  2024cites this paper
• Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes.

  2024cites this paper
• Prophylactic Antimicrobials for Prevention of Febrile Neutropenia in Tumour-Bearing Dogs Treated With Lomustine.

  2024cites this paper
• Levofloxacin prophylaxis for pediatric leukemia patients: monitoring of outcomes for sustained benefit and consequences

  2024cites this paper
• Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation

  2024cites this paper
• Antibiotic practice and stewardship in the management of neutropenic fever: a survey of US institutions

  2024cites this paper
• Ciprofloxacin prophylaxis during haematopoietic cell transplantation: a role for use in patients with germ cell tumours?

  2024cites this paper
• Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

  2024cites this paper
• No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC

  2024cites this paper
• Patterns of fluoroquinolone utilization and resistance in a tertiary care hospital: a retrospective cross-sectional analysis study from a developing country

  2024cites this paper
• Prevention and treatment of bacterial infections in patients with haematological cancers and hematopoietic stem cell transplantation: headways and shortcomings.

  2024cites this paper
• Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology Patients

  2023cites this paper
• Infections of Tumor Prostheses: An Updated Review on Risk Factors, Microbiology, Diagnosis, and Treatment Strategies

  2023cites this paper
• Fluoroquinolone Prophylaxis during Conventional Chemotherapy or Hematopoietic Stem Cell Transplantation for Acute Leukemia – Pros and Cons

  2023influential citation
• Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period

  2023cites this paper
• Prevalence of Pseudomonas aeruginosa and its antibiotic resistance in patients who have received Hematopoietic Stem-Cell Transplantation; A globally Systematic Review.

  2023cites this paper
• Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil

  2023cites this paper
• Supportive Care for Patients With Myelodysplastic Syndromes

  2023cites this paper
• Oncological outcomes of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5‐fluorouracil for locally advanced squamous cell carcinoma of the external auditory canal: A single‐center study

  2023cites this paper
• Effectiveness of levofloxacin in the induction of chemotherapy in high-risk acute lymphoblastic leukaemia in children in a developing country

  2023cites this paper
• The effect of ciprofloxacin prophylaxis during haematopoietic cell transplantation on infection episodes, exposure to treatment antimicrobials and antimicrobial resistance: a single-centre retrospective cohort study

  2023cites this paper
• Screening for multidrug‐resistant organisms in high‐risk hospitalized patients with hematologic diseases

  2023cites this paper
• Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study

  2023cites this paper
• Comparative Effectiveness and Safety of Antibiotic Prophylaxis During Induction Chemotherapy in Children with Acute Leukaemia: A Systematic Review and Meta-analysis.

  2023cites this paper
• Antibiotic prophylaxis in acute childhood leukemia: What is known so far?

  2022cites this paper
• Antibacterial and Cytotoxic Compounds from Endophyte Fusarium solani isolated from Centella asiatica (L.)

  2022cites this paper
• Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow‐up for impact on health care‐associated infections

  2022cites this paper
• Effectiveness of Quinolone Prophylaxis in Pediatric Acute Leukemia and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis

  2022cites this paper
• Delay in Time to Antibiotics for De Novo Inpatient Neutropenic Fever May Not Impact Overall Survival for Patients With a Cancer Diagnosis.

  2022cites this paper
• Urinary Tract Infections in Patients with Solid Tumors: Retrospective Study

  2022cites this paper
• Rapid Administration of Antibiotics for Reducing Fever Days in Patients Receiving Hematopoietic Stem Cell Transplantation

  2022cites this paper
• Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression

  2022cites this paper
• Adaptation of Bacteria to Antineoplastic Agents Involves Persister Cells and Increases Resistance to Antibiotics

  2022cites this paper
• Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients

  2022cites this paper
• Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis

  2022cites this paper
• Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients.

  2022cites this paper
• SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)

  2022influential citation
• Burden, risk factors, and management of neutropenic fever among solid cancer patients in Ethiopia

  2022influential citation
• Neutropenia and Infection Prophylaxis in Childhood Cancer

  2022cites this paper
• Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma

  2022cites this paper
• Indicaciones para la prevención de infecciones en el paciente inmunocomprometido

  2022cites this paper
• Das Hodgkin-Lymphom in fortgeschrittenen Stadien

  2022cites this paper
• Infections et cytopénies… impact sur et de l’immunothérapie

  2022cites this paper
• Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States

  2022cites this paper
• Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.

  2022cites this paper
• Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy

  2022cites this paper
• Efficacy and Safety of Levofloxacin Prophylaxis During Induction Therapy for Childhood Acute Lymphoblastic Leukemia

  2022cites this paper
• Levofloxacin Versus Ciprofloxacin-Based Prophylaxis during the Pre-Engraftment Phase in Allogeneic Hematopoietic Stem Cell Transplant Pediatric Recipients: A Single-Center Retrospective Matched Analysis

  2021cites this paper
• Colonization with Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.

  2021cites this paper
• Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis

  2021cites this paper
• Antibakterielle Prophylaxe in der Pädiatrischen Hämatologie und Onkologie

  2021cites this paper
• Omitting ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and microbiome structure.

  2021cites this paper
• Diabetes and Cancer: Risk, Challenges, Management and Outcomes

  2021cites this paper
• Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

  2021cites this paper
• Reply to Caldwell et al.

  2021cites this paper
• Clinical and microbiological impact of long‐term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia

  2021cites this paper
• 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation.

  2021cites this paper
• Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer

  2021cites this paper
• Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patients

  2021cites this paper
• Advances in acute myeloid leukemia

  2021cites this paper
• Adapting Supportive Care Guidelines from High-income Countries; Real World Data on Approach to Neutropenic Sepsis in Haemato-Oncology Patients in Sri Lanka

  2021cites this paper
• Inverse Probability Weighting-based Mediation Analysis for Microbiome Data

  2021cites this paper
• Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia

  2021cites this paper
• Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation

  2021cites this paper
• Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

  2021cites this paper
• Antibakterielle Prophylaxe in der Hämatologie und Onkologie

  2021cites this paper
• Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation

  2021cites this paper
• Microbiome implications in transplantation and oncology

  2021cites this paper
• Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count‐driven approach

  2021cites this paper
• Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy

  2021cites this paper
• Predicting fever in neutropenia with safety‐relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study

  2021cites this paper
• Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation

  2021cites this paper
• Treatment of Secondary Immunodeficiencies

  2021cites this paper
• Management of the Older Patient with Myelodysplastic Syndrome

  2021cites this paper
• Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia: comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice

  2021cites this paper
• Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic

  2020cites this paper